Chronic intestinal inflammation and immunosuppressive therapies, such as tumor necrosis factor (TNF) inhibitors, may impair macrophage function and increase susceptibility to bacterial persistence and defective intracellular clearance, potentially predisposing patients to malakoplakia [4,12]. The gene discussed is TNF; the disease is malakoplakia.